Healthcare provider profile · identity verified

Steven R Mills, DO

Allopathic & Osteopathic Physicians|Family Medicine · ROCKPORT, IN · NPI 1801019880

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Steven R Mills, DO received $87.59 in general payments during 2025 across 5 reported records.

ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) accounted for 36.0% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 4 associated products.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$87.59

5 reported records · 4 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)	Unresolved — no canonical attribution shown	$31.58	36.0%	2	2025
Axsome Therapeutics, Inc.	Unresolved — no canonical attribution shown	$22.92	26.2%	1	2025
Vanda Pharmaceuticals Inc.	Unresolved — no canonical attribution shown	$19.17	21.9%	1	2025
Corcept Therapeutics	Unresolved — no canonical attribution shown	$13.92	15.9%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$87.59	5

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
CAPLYTA Normalized: caplyta	Drug	ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)	$31.58	2	2025
Source payment records 2025-10-21 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $15.31 · Open Payments source 2025-12-02 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $16.27 · Open Payments source
Auvelity Normalized: auvelity	Drug	Axsome Therapeutics, Inc.	$22.92	1	2025
Source payment records 2025-10-24 · Axsome Therapeutics, Inc. · $22.92 · Open Payments source
FANAPT Normalized: fanapt	Drug	Vanda Pharmaceuticals Inc.	$19.17	1	2025
Source payment records 2025-11-13 · Vanda Pharmaceuticals Inc. · $19.17 · Open Payments source
Korlym Normalized: korlym	Drug	Corcept Therapeutics	$13.92	1	2025
Source payment records 2025-11-20 · Corcept Therapeutics · $13.92 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Omeprazole	Omeprazole	474	91
Lisinopril	Lisinopril	398	81
Levothyroxine Sodium	Levothyroxine Sodium	377	70
Atorvastatin Calcium	Atorvastatin Calcium	368	71
Montelukast Sodium	Montelukast Sodium	368	83
Gabapentin	Gabapentin	318	64
Albuterol Sulfate Hfa	Albuterol Sulfate	283	62
Pantoprazole Sodium	Pantoprazole Sodium	276	56
Furosemide	Furosemide	271	63
Losartan Potassium	Losartan Potassium	264	56
Amlodipine Besylate	Amlodipine Besylate	232	54
Simvastatin	Simvastatin	229	52
Clopidogrel	Clopidogrel Bisulfate	217	42
Glipizide	Glipizide	217	47
Hydrochlorothiazide	Hydrochlorothiazide	215	39
Metoprolol Succinate	Metoprolol Succinate	194	43
Trazodone Hcl	Trazodone Hcl	191	42
Atenolol	Atenolol	183	30
Potassium Chloride	Potassium Chloride	174	41
Pioglitazone Hcl	Pioglitazone Hcl	172	38
Alprazolam	Alprazolam	168	25
Topiramate	Topiramate	159	27
Ezetimibe	Ezetimibe	154	31
Rosuvastatin Calcium	Rosuvastatin Calcium	147	29
Promethazine Hcl	Promethazine Hcl	141	15
Sertraline Hcl	Sertraline Hcl	137	23
Celecoxib	Celecoxib	132	31
Escitalopram Oxalate	Escitalopram Oxalate	131	22
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	126	37
Carvedilol	Carvedilol	125	25
Citalopram Hbr	Citalopram Hydrobromide	124	24
Metformin Hcl	Metformin Hcl	123	26
Famotidine	Famotidine	119	24
Buspirone Hcl	Buspirone Hcl	115	26
Meloxicam	Meloxicam	115	23
Ozempic	Semaglutide	115	18
Esomeprazole Magnesium	Esomeprazole Magnesium	108	20
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	107	23
Pravastatin Sodium	Pravastatin Sodium	107	24
Metoprolol Tartrate	Metoprolol Tartrate	106	23
Eliquis	Apixaban	102	19
Allopurinol	Allopurinol	101	25
Tamsulosin Hcl	Tamsulosin Hcl	97	31
Zolpidem Tartrate	Zolpidem Tartrate	96	15
Tizanidine Hcl	Tizanidine Hcl	94	25
Duloxetine Hcl	Duloxetine Hcl	93	22
Ropinirole Hcl	Ropinirole Hcl	87	18
Diazepam	Diazepam	85	12
Lovastatin	Lovastatin	80	17
Meclizine Hcl	Meclizine Hcl	77	21
Clonazepam	Clonazepam	76	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	73	14
Fluoxetine Hcl	Fluoxetine Hcl	70	11
Ondansetron Hcl	Ondansetron Hcl	69	27
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	68	suppressed
Januvia	Sitagliptin Phosphate	68	18
Clonidine Hcl	Clonidine Hcl	66	11
Methylprednisolone	Methylprednisolone	65	53
Diclofenac Sodium	Diclofenac Sodium	61	20
Torsemide	Torsemide	61	15
Fluticasone Propionate	Fluticasone Propionate	60	22
Donepezil Hcl	Donepezil Hcl	59	13
Quetiapine Fumarate	Quetiapine Fumarate	59	suppressed
Ventolin Hfa	Albuterol Sulfate	59	22
Hydroxyzine Hcl	Hydroxyzine Hcl	57	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	57	15
Mounjaro	Tirzepatide	57	15
Isosorbide Mononitrate Er	Isosorbide Mononitrate	55	suppressed
Prednisone	Prednisone	55	23
Estradiol	Estradiol	54	suppressed
Tramadol Hcl	Tramadol Hcl	54	14
Amitriptyline Hcl	Amitriptyline Hcl	53	11
Ibuprofen	Ibuprofen	51	13
Azithromycin	Azithromycin	50	33
Metformin Hcl Er	Metformin Hcl	49	suppressed
Amoxicillin	Amoxicillin	47	34
Lorazepam	Lorazepam	46	suppressed
Sucralfate	Sucralfate	46	12
Warfarin Sodium	Warfarin Sodium	45	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	43	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	43	suppressed
Testosterone Cypionate	Testosterone Cypionate	43	suppressed
Eszopiclone	Eszopiclone	42	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	41	suppressed
Ondansetron Odt	Ondansetron	41	suppressed
Paroxetine Hcl	Paroxetine Hcl	41	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	40	32
Jardiance	Empagliflozin	40	suppressed
Finasteride	Finasteride	39	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	37	13
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	37	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	37	suppressed
Megestrol Acetate	Megestrol Acetate	35	14
Rybelsus	Semaglutide	35	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	34	13
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	33	suppressed
Fluconazole	Fluconazole	33	19
Colestipol Hcl	Colestipol Hcl	32	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	32	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	32	22
Triamcinolone Acetonide	Triamcinolone Acetonide	32	suppressed
Bupropion Hcl Sr	Bupropion Hcl	31	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	31	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	31	suppressed
Cilostazol	Cilostazol	30	suppressed
Synthroid	Levothyroxine Sodium	30	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	30	suppressed
Lactulose	Lactulose	29	suppressed
Lansoprazole	Lansoprazole	29	suppressed
Ramipril	Ramipril	29	suppressed
Valacyclovir	Valacyclovir Hcl	29	11
Creon	Lipase/Protease/Amylase	28	suppressed
Memantine Hcl	Memantine Hcl	28	suppressed
Mirtazapine	Mirtazapine	28	suppressed
Spironolactone	Spironolactone	28	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	28	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	27	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	27	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	27	suppressed
Verapamil Hcl	Verapamil Hcl	27	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	26	16
Venlafaxine Hcl	Venlafaxine Hcl	26	suppressed
Digoxin	Digoxin	25	suppressed
Enalapril Maleate	Enalapril Maleate	25	suppressed
Nifedipine Er	Nifedipine	25	suppressed
Propranolol Hcl	Propranolol Hcl	25	suppressed
Symbicort	Budesonide/Formoterol Fumarate	25	suppressed
Benazepril Hcl	Benazepril Hcl	24	suppressed
Cephalexin	Cephalexin	24	17
Levofloxacin	Levofloxacin	24	21
Baclofen	Baclofen	23	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	23	suppressed
Enbrel	Etanercept	23	suppressed
Levetiracetam	Levetiracetam	23	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	22	suppressed
Olanzapine	Olanzapine	22	suppressed
Bupropion Xl	Bupropion Hcl	21	suppressed
Glimepiride	Glimepiride	21	suppressed
Glipizide Er	Glipizide	21	suppressed
Methocarbamol	Methocarbamol	21	suppressed
Solifenacin Succinate	Solifenacin Succinate	21	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	21	suppressed
Spiriva Handihaler	Tiotropium Bromide	20	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	20	suppressed
Pregabalin	Pregabalin	19	suppressed
Temazepam	Temazepam	19	suppressed
Anastrozole	Anastrozole	18	suppressed
Gemfibrozil	Gemfibrozil	18	suppressed
Linzess	Linaclotide	18	suppressed
Novolog Mix 70-30	Insulin Aspart Prot/Insuln Asp	18	suppressed
Alendronate Sodium	Alendronate Sodium	17	suppressed
Dexlansoprazole Dr	Dexlansoprazole	17	suppressed
Prasugrel Hcl	Prasugrel Hcl	17	suppressed
Raloxifene Hcl	Raloxifene Hcl	17	suppressed
Clindamycin Hcl	Clindamycin Hcl	16	12
Hydralazine Hcl	Hydralazine Hcl	16	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	16	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	16	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	16	suppressed
Verapamil Er	Verapamil Hcl	16	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	15	13
Farxiga	Dapagliflozin Propanediol	15	suppressed
Flecainide Acetate	Flecainide Acetate	15	suppressed
Myrbetriq	Mirabegron	15	suppressed
Theo-24	Theophylline Anhydrous	15	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	14	suppressed
Darifenacin Er	Darifenacin Hydrobromide	14	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	14	suppressed
Metronidazole	Metronidazole	14	12
Nortriptyline Hcl	Nortriptyline Hcl	14	suppressed
Timolol Maleate	Timolol Maleate	14	suppressed
Valsartan	Valsartan	14	suppressed
Ampicillin Trihydrate	Ampicillin Trihydrate	13	suppressed
Constulose	Lactulose	13	suppressed
Divalproex Sodium	Divalproex Sodium	13	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	13	suppressed
Novolog	Insulin Aspart	13	suppressed
Oxycodone Hcl	Oxycodone Hcl	13	suppressed
Risperidone	Risperidone	13	suppressed
Terazosin Hcl	Terazosin Hcl	13	suppressed
Belsomra	Suvorexant	12	suppressed
Colchicine	Colchicine	12	suppressed
Febuxostat	Febuxostat	12	suppressed
Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	12	suppressed
Levemir	Insulin Detemir	12	suppressed
Loperamide	Loperamide Hcl	12	suppressed
Modafinil	Modafinil	12	suppressed
Nadolol	Nadolol	12	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	12	suppressed
Rinvoq	Upadacitinib	12	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	12	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	11	11
Breyna	Budesonide/Formoterol Fumarate	11	suppressed
Bumetanide	Bumetanide	11	suppressed
Felbamate	Felbamate	11	suppressed
Indomethacin Er	Indomethacin	11	suppressed
Nitroglycerin Patch	Nitroglycerin	11	suppressed
Repaglinide	Repaglinide	11	suppressed
Vilazodone Hcl	Vilazodone Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$87.59 · 5 records	ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)	Auvelity, CAPLYTA, FANAPT, Korlym	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error